Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer
Paolo Tarantino, Se-Eun Kim, Melissa E. Hughes, Ross J. Kusmick et autres
us, it, es (code pays fourni par la source)
2 citations
npj Precision Oncology